Ammuravid, a study coordinated by the universities of Verona and Milan and promoted by the Italian Society of Infectious and Tropical Diseases, opens up new therapeutic possibilities for patients affected by Covid-19. The Italian Medicines Agency – AIFA has approved the trial, designed to assess the effectiveness of immunotherapy, in addition to antivirals, in treating Covid-19 hospital patients. The Project Coordinator for the University of...

Leggi tutto...